Analona Therapeutics ApS

CVR 44958821 · Private limited company (ApS) · Active · Medium risk

Analona Therapeutics ApS is a Private limited company (ApS), founded on , based in Nykøbing F. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK -857k and a net result of DKK -897k.

Bankruptcy risk for Analona Therapeutics ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 75% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Published annual reports1 · bankruptcy rate 18.7%2.1×
CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×
Registered owners2 · bankruptcy rate 7.6%0.87×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44958821
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
c/o Beierholm, Herningvej 34
4800 Nykøbing F
Municipality
Guldborgsund
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 40k
Auditor
Beierholm
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityYes
Equity ratio-18.7%
Current ratio739%
Moves (last 2 years)1
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address8
Going-concern uncertaintyYes

Financials and key figures

Financial year2025
Gross profitDKK 508k
Net profitDKK -897k
EquityDKK -857k
Total assetsDKK 4.6m
CashDKK 1.3m
Short-term debtDKK 179k
Avg. employees1

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
9 Jul 2024 – 31 Dec 2025176

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMikkel Wandahl Pedersen
CEOAxel Johannes Behrens
Owner (25%)Mikkel Wandahl PedersenCurrent
Owner (67%)AB BIO GmbHCurrent
FounderMikkel Wandahl PedersenCurrent
FounderAB BIO GmbHCurrent

The CEOs' other companies

Mikkel Wandahl Pedersen – 1 other companies

Address history (1 moves)

c/o Beierholm, Herningvej 34, 4800 Nykøbing F
c/o BII, Ole Maaløes Vej 3, 2200 København N

Other companies at the same address

Questions and answers about Analona Therapeutics ApS

Has Analona Therapeutics ApS gone bankrupt?

No, Analona Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Analona Therapeutics ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the auditor of Analona Therapeutics ApS?

Analona Therapeutics ApS most recently used Beierholm.

When was Analona Therapeutics ApS founded?

Analona Therapeutics ApS was founded on 9 July 2024.

What is the equity of Analona Therapeutics ApS?

Equity was DKK -857k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.